• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早发性乳腺癌患者中符合遗传性乳腺癌和卵巢癌及李-佛美尼综合征的致病性变异。

Pathogenic Variants in Early-Onset Breast Cancer Patients Fulfilling Hereditary Breast and Ovary Cancer and Li-Fraumeni-like Syndromes.

机构信息

Laboratory of Molecular Genetics and Cytogenetics, Institute of Biological Sciences I (ICB I), Federal University of Goiás, Goiânia 74690900, Brazil.

Clinical of Hospital (HC), Federal University of Goiás (UFG), Goiânia 74690900, Brazil.

出版信息

Biomolecules. 2022 Apr 27;12(5):640. doi: 10.3390/biom12050640.

DOI:10.3390/biom12050640
PMID:35625568
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9138348/
Abstract

gene mutation is the most common genetic alteration in human malignant tumors and is mainly responsible for Li-Fraumeni syndrome. Among the several cancers related to this syndrome, breast cancer (BC) is the most common. The p.R337H germline pathogenic variant is highly prevalent in Brazil's South and Southeast regions, accounting for 0.3% of the general population. We investigated the prevalence of germline pathogenic variants in a cohort of 83 BC patients from the Midwest Brazilian region. All patients met the clinical criteria for hereditary breast and ovarian cancer syndrome (HBOC) and were negative for and mutations. Moreover, 40 index patients fulfilled HBOC and the Li-Fraumeni-like (LFL) syndromes criteria. The samples were tested using next generation sequencing for . Three patients harbored missense pathogenic variants (p.Arg248Gln, p.Arg337His, and p.Arg337Cys), confirmed by Sanger sequencing. One (1.2%) patient showed a large deletion (exons 2-11), which was also confirmed. The p.R337H variant was detected in only one patient. In conclusion, four (4.8%) early-onset breast cancer patients fulfilling the HBOC and LFL syndromes presented pathogenic variants, confirming the relevance of genetic tests in this group of patients. In contrast to other Brazilian regions, p.R337H variant appeared with low prevalence.

摘要

基因突变是人类恶性肿瘤中最常见的遗传改变,主要导致 Li-Fraumeni 综合征。在与该综合征相关的几种癌症中,乳腺癌(BC)最为常见。p.R337H 种系致病性变异在巴西南部和东南部地区非常普遍,占总人口的 0.3%。我们调查了来自巴西中西部地区的 83 例 BC 患者队列中种系致病性变异的流行情况。所有患者均符合遗传性乳腺癌和卵巢癌综合征(HBOC)的临床标准,且为阴性。此外,40 名指数患者符合 HBOC 和 Li-Fraumeni 样(LFL)综合征标准。使用下一代测序对进行了测试。有 3 名患者携带种系错义致病性变异(p.Arg248Gln、p.Arg337His 和 p.Arg337Cys),经 Sanger 测序证实。1 名(1.2%)患者显示出较大的缺失(外显子 2-11),也得到了证实。仅在 1 名患者中检测到 p.R337H 变异。总之,4 名(4.8%)符合 HBOC 和 LFL 综合征的早发性乳腺癌患者存在种系致病性变异,证实了遗传检测在这组患者中的重要性。与巴西其他地区相比,p.R337H 变异的出现频率较低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f12/9138348/163be1a3fa5f/biomolecules-12-00640-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f12/9138348/163be1a3fa5f/biomolecules-12-00640-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f12/9138348/163be1a3fa5f/biomolecules-12-00640-g001.jpg

相似文献

1
Pathogenic Variants in Early-Onset Breast Cancer Patients Fulfilling Hereditary Breast and Ovary Cancer and Li-Fraumeni-like Syndromes.早发性乳腺癌患者中符合遗传性乳腺癌和卵巢癌及李-佛美尼综合征的致病性变异。
Biomolecules. 2022 Apr 27;12(5):640. doi: 10.3390/biom12050640.
2
Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.巴西南部儿童癌症患者中李-佛美尼综合征和李-佛美尼样综合征。
Cancer. 2013 Dec 15;119(24):4341-9. doi: 10.1002/cncr.28346. Epub 2013 Oct 7.
3
Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation.巴西个体中 TP53 p.R337H 突变的 Li-Fraumeni 综合征/Li-Fraumeni 样综合征的临床谱。
J Steroid Biochem Mol Biol. 2019 Jun;190:250-255. doi: 10.1016/j.jsbmb.2019.04.011. Epub 2019 Apr 8.
4
Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity.疑似李-佛美尼综合征的乳腺癌患者:突变谱、候选基因和无法解释的遗传。
Breast Cancer Res. 2018 Aug 7;20(1):87. doi: 10.1186/s13058-018-1011-1.
5
p.R337H Germline Variant among Women at Risk of Hereditary Breast Cancer in a Public Health System of Midwest Brazil.巴西中西部公共卫生系统中遗传性乳腺癌风险女性的 p.R337H 种系变异。
Genes (Basel). 2024 Jul 16;15(7):928. doi: 10.3390/genes15070928.
6
The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.TP53基因的R337H突变与巴西家族中的李-佛美尼综合征及李-佛美尼样综合征相关。
Cancer Lett. 2007 Jan 8;245(1-2):96-102. doi: 10.1016/j.canlet.2005.12.039. Epub 2006 Feb 21.
7
Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.在一个多民族亚洲队列中,BRCA1、BRCA2 和 TP53 种系突变的频率相当,这表明应向早发性乳腺癌患者提供与 BRCA1/2 筛查相结合的 TP53 筛查。
Breast Cancer Res. 2012 Apr 16;14(2):R66. doi: 10.1186/bcr3172.
8
Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set: An International Agency for Research on Cancer TP53 Database Analysis.基于国际胚系 TP53 变异数据集中的 Li-Fraumeni 谱分析:国际癌症研究机构 TP53 数据库分析。
JAMA Oncol. 2021 Dec 1;7(12):1800-1805. doi: 10.1001/jamaoncol.2021.4398.
9
Radiotherapy-induced malignancies in breast cancer patients with TP53 pathogenic germline variants (Li-Fraumeni syndrome).TP53 种系致病性变异(李-佛美尼综合征)乳腺癌患者的放疗诱导性恶性肿瘤。
Fam Cancer. 2020 Jan;19(1):47-53. doi: 10.1007/s10689-019-00153-5.
10
TP53 p.R337H prevalence in a series of Brazilian hereditary breast cancer families.一系列巴西遗传性乳腺癌家族中TP53 p.R337H的患病率
Hered Cancer Clin Pract. 2014 Mar 13;12(1):8. doi: 10.1186/1897-4287-12-8.

引用本文的文献

1
Systematic review of the molecular basis of hereditary breast and ovarian cancer syndrome in Brazil: the current scenario.巴西遗传性乳腺癌和卵巢癌综合征分子基础的系统评价:现状。
Eur J Med Res. 2024 Mar 20;29(1):187. doi: 10.1186/s40001-024-01767-x.
2
p53 Function and Dysfunction in Human Health and Diseases.p53 在人类健康与疾病中的功能与失能。
Biomolecules. 2023 Mar 9;13(3):506. doi: 10.3390/biom13030506.

本文引用的文献

1
Frequency of the TP53 R337H variant in sporadic breast cancer and its impact on genomic instability.散发性乳腺癌中 TP53 R337H 变异的频率及其对基因组不稳定性的影响。
Sci Rep. 2020 Oct 6;10(1):16614. doi: 10.1038/s41598-020-73282-y.
2
, , and genetic profile in Moroccan triple negative breast cancer cases.摩洛哥三阴性乳腺癌病例中的[具体内容缺失,原文此处不完整]、[具体内容缺失,原文此处不完整]和基因图谱。
Int J Mol Epidemiol Genet. 2020 Jun 15;11(1):16-25. eCollection 2020.
3
Current review of TP53 pathogenic germline variants in breast cancer patients outside Li-Fraumeni syndrome.
乳腺癌患者中 Li-Fraumeni 综合征以外的 TP53 种系变异的最新研究进展。
Hum Mutat. 2018 Dec;39(12):1764-1773. doi: 10.1002/humu.23656. Epub 2018 Oct 3.
4
Clinical implications of germline mutations in breast cancer: TP53.乳腺癌种系突变的临床意义:TP53。
Breast Cancer Res Treat. 2018 Jan;167(2):417-423. doi: 10.1007/s10549-017-4531-y. Epub 2017 Oct 16.
5
A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families.在西班牙一系列疑似李-弗劳梅尼综合征的家族中鉴定出一种新型的TP53生殖系框内缺失。
Fam Cancer. 2017 Oct;16(4):567-575. doi: 10.1007/s10689-017-9990-0.
6
Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.美国国立癌症研究所李-弗劳梅尼综合征队列中TP53突变携带者首次患癌及后续患癌风险
Cancer. 2016 Dec 1;122(23):3673-3681. doi: 10.1002/cncr.30248. Epub 2016 Aug 6.
7
Germline mutations in BRCA1, BRCA2, CHEK2 and TP53 in patients at high-risk for HBOC: characterizing a Northeast Brazilian Population.HBOC高危患者中BRCA1、BRCA2、CHEK2和TP53的生殖系突变:对巴西东北部人群的特征分析
Hum Genome Var. 2014 Oct 16;1:14012. doi: 10.1038/hgv.2014.12. eCollection 2014.
8
Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families.对一大群多病例乳腺癌和卵巢癌家族中一组假定的乳腺癌易感基因进行靶向大规模平行测序。
J Med Genet. 2016 Jan;53(1):34-42. doi: 10.1136/jmedgenet-2015-103452. Epub 2015 Nov 3.
9
Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers.重新审视携 TP53 突变者的李-佛美尼综合征。
J Clin Oncol. 2015 Jul 20;33(21):2345-52. doi: 10.1200/JCO.2014.59.5728. Epub 2015 May 26.
10
Prevalence of the TP53 p.R337H mutation in breast cancer patients in Brazil.巴西乳腺癌患者中TP53基因p.R337H突变的患病率。
PLoS One. 2014 Jun 17;9(6):e99893. doi: 10.1371/journal.pone.0099893. eCollection 2014.